Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study-Reference-Cited by-同舟云学术

Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study

Published:2010-07 Issue:7 Volume:32 Page:1252-1269
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Oparil Suzanne,Melino Michael,Lee James,Fernandez Victor,Heyrman Reinilde

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference31 articles.

1. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008;Egan;JAMA.,2010

2. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report [published correction appears in JAMA. 2003;290:197];Chobanian;JAMA.,2003

3. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: The VALUE randomised trial;Julius;Lancet.,2004

4. Does earlier attainment of blood pressure goal translate into fewer cardiovascular events?;Nasser;Curr Hypertens Rep.,2008

5. Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial;Staessen;J Hypertens.,2004

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Initial Combination Therapies;Hypertension;2024

2. Real-World Effectiveness and Safety of a Single-Pill Combination of Olmesartan/Amlodipine/Hydrochlorothiazide in Korean Patients with Hypertension and Cardiovascular Risk Factors;Advances in Therapy;2023-08-31

3. Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double‐blind, active‐controlled, multicenter phase 3 trial;The Journal of Clinical Hypertension;2023-08-23

4. Role of Angiotensin II in Cardiovascular Diseases: Introducing Bisartans as a Novel Therapy for Coronavirus 2019;Biomolecules;2023-05-02

5. Hypertension therapy using fixed-dose polypills that contain at least three medications;Heart;2023-02-21